IDenta Corporation

Drug, Explosive, and Forensic Detection Products

Aerospace, Defense & HLS
Public on OTC on Feb, 2002
Follow

Company Overview

Snapshot

Founded in November 1994 by Baruch Glattstein, IDenta Corporation operates with 1–10 employees. The company has raised a total of $5 million across two funding rounds. IDenta Corporation went public on the OTC in February 2002, marking a significant milestone in its corporate trajectory.

Business overview

IDenta Corporation specializes in developing proprietary onsite detection kits for drugs and explosives, alongside unique forensic products. Its patented technology allows for rapid detection and identification of substances, liquids, and traces at nanogram levels within seconds. These kits are designed to be portable, user-friendly, robust, reliable, and safe. IDenta serves government agencies such as police, military, airports, and customs, as well as civilian markets including parents, workplaces, and schools. The company operates within the Aerospace, Defense & HLS sector, focusing on security technologies, sensing, and diagnostic solutions.

Strategic signal

IDenta Corporation reported its strongest first quarter ever in May 2026, driven by continued profitability and a strengthened balance sheet for global expansion. This financial performance signals robust operational efficiency and successful market penetration, positioning the company for sustained growth within the defense and security sectors.

Log in to access full profile

Company Intelligence Q&A

What were IDenta Corporation's financial results for the first quarter of 2026?
IDenta Corporation reported its strongest first quarter ever in May 2026, with results indicating continued profitability and a strengthened balance sheet, supporting global expansion efforts.
What were IDenta Corporation's financial results for the full year 2025?
In March 2026, IDenta Corporation reported its 2025 financial results, achieving continued profitability and strengthening its balance sheet to support global expansion initiatives.
What strategic focus did IDenta Corporation highlight at the Defense Tech Expo in February 2026?
At the Defense Tech Expo in February 2026, IDenta Corporation's CEO, Amichai Glattstein, highlighted the company's rapid forensic screening tools, capitalizing on Israel's defense-tech boom. The company, which collaborates with Dyson, aims to expand its one-time use testing kits for drugs and explosives from government agencies into consumer markets like schools and workplaces.
What were IDenta Corporation's financial results for the third quarter of 2025?
In November 2025, IDenta Corp. reported a significant increase in sales for the third quarter of 2025 compared to the same period in 2024, with revenues reaching $427,519 and gross profit increasing to $194,038. The company emphasized strong liquidity and expanding customer partnerships for future growth.
What significant contract did IDenta Corp sign in September 2019?
In September 2019, IDenta Corp. signed a $2.5 million contract with an Asian country to supply its drug and explosive detection products over five years, marking the largest contract in the company's history and signaling significant international growth potential.
Log in to access full profile